| Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle TJ Gardner, T Cohen, V Redmann, Z Lau, D Felsenfeld, D Tortorella Antiviral research 113, 49-61, 2015 | 41 | 2015 |
| A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: individualized T cell epitope measure (iTEM) T Cohen, L Moise, M Ardito, W Martin, AS De Groot BioMed Research International 2010, 2010 | 40 | 2010 |
| The strengths and weaknesses of viscoelastic testing compared to traditional coagulation testing T Cohen, T Haas, MM Cushing Transfusion 60, S21-S28, 2020 | 37 | 2020 |
| Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial RK Dyer, MA Weinstock, TSD Cohen, AE Rizzo, SF Bingham, ... Journal of investigative dermatology 132 (11), 2544-2551, 2012 | 34 | 2012 |
| Convallatoxin-induced reduction of methionine import effectively inhibits human cytomegalovirus infection and replication T Cohen, JD Williams, TJ Opperman, R Sanchez, NS Lurain, D Tortorella Journal of Virology 90 (23), 10715-10727, 2016 | 33 | 2016 |
| The microtubule inhibitor podofilox inhibits an early entry step of human cytomegalovirus T Cohen, TM Schwarz, F Vigant, TJ Gardner, RE Hernandez, B Lee, ... Viruses 8 (10), 295, 2016 | 20 | 2016 |
| Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial MY Xiong, AE Rizzo, TSD Cohen, RK Dyer, K Korgavkar, SF Bingham, ... Journal of Investigative Dermatology 133 (6), 1521-1532, 2013 | 19 | 2013 |
| Valspodar limits human cytomegalovirus infection and dissemination AJ Parsons, T Cohen, TM Schwarz, KR Stein, SI Ophir, JP Casado, ... Antiviral research 193, 105124, 2021 | 6 | 2021 |
| Immunoinformatics: the next step in vaccine design T Cohen, L Moise, W Martin, AS De Groot Infectious Disease Informatics, 223-244, 2010 | 6 | 2010 |
| Use of bioinformatics to predict MHC ligands and T-cell epitopes: application to epitope-driven vaccine design AS De Groot, T Cohen, M Ardito, L Moise, B Martin, JA Berzofsky Methods in Microbiology 37, 35-66, 2010 | 5 | 2010 |
| Granulocyte transfusion: Clinical updates and a practical approach to transfusion T Cohen, SC Simmons, HP Pham, EM Staley Clinics in Laboratory Medicine 41 (4), 647-657, 2021 | 3 | 2021 |
| Characterization of Use of Cryoprecipitate in Perioperative Bleeding MM Cushing, S Rand, M Fitzgerald, T Cohen, P Rajendran, J Littlejohn, ... 2022 Annual Meeting, 2022 | | 2022 |
| Exploiting Small Molecule Drugs to Study Cytomegalovirus Infection TSD Cohen Icahn School of Medicine at Mount Sinai, 2016 | | 2016 |
| Predictors of squamous cell carcinoma in a high-risk population: VA Topical Tretinoin Chemoprevention Trial (VATTC) AE Rizzo, RK Dyer, T Cohen, MA Weinstock JOURNAL OF INVESTIGATIVE DERMATOLOGY 132, S42-S42, 2012 | | 2012 |
| Reducing Protein Immunogenicity by Design: Deimmunization and Tolerance Induction AS De Groot, T Cohen, L Moise, WD Martin Proceedings of the 21st Annual Meeting of the European Society for Animal …, 2012 | | 2012 |
| Tracking highly conserved and immunogenic cross-clade HIV CTL epitopes included the GAIA HIV vaccine over time K Sangare, O Koita, K Tounkara, Z Koty, L Moise, M Ardito, T Cohen, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 26 (10), A136-A136, 2010 | | 2010 |
| Species neutral correlates of immunogenicity for vaccines and protein therapeutics: Fact or Science Fiction AS De Groot, M Baker, T Cohen Human vaccines 6 (5), 368-372, 2010 | | 2010 |
